Currently or recently pregnant (recently pregnant defined as enrollment within 1 year of pregnancy outcome)
Received at least one dose of PENBRAYA during pregnancy or within 30 days prior to last menstrual period (LMP)
Personally signed and dated informed consent document or, upon waiver of written consent by the relevant IRB/independent ethics committee, verbal consent, indicating that the individual (or a legally acceptable representative) has been informed of all pertinent aspects of the study
Authorization for the enrolled participants' health care provider(s) (HCP\[s\]) to provide data to the registry
